Skip to main content

Table 2 Baseline information and the duration from NAIs therapy to H7N9 virus-negative

From: Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study

Patients

Characteristics

O + P

O

P Value

All patients

n = 39

n = 43

 

Patients whose virus still positive till death

n = 7

n = 5

 

Study patients

n = 32

n = 38

 
 

Age (years): mean (SD)

55.22(14.25)

60.21(14.89)

0.64

 

No. of male (%)

22(68.75 %)

27(71.05 %)

1.00

 

Time from symptom onset to NAIs administration (days):median (IQR)

7.00(4.25, 8.75)

5.00(4.00, 7.00)

0.52

 

APACHE II score: mean(SD)

17.47(8.08)

20.82(8.17)

0.87

 

Viral load(log10 /ul) at day 0: median(IQR)

3.30(2.91, 4.1)

3.29(2.70, 4.47)

0.12

 

Duration from NAIs taken to H7N9 virus negative(days): median(IQR)

7.00(6.00, 9.75)

6.50(4.00, 8.00)

0.67

  1. O oseltamivir monotherapy, O+P oseltamivir-peramivir combination therapy, IQR interquartile range, percentile 25 – percentile75